Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clearance for BrainLAB's dose algorithm

This article was originally published in Clinica

Executive Summary

The Monte Carlo dose calculation algorithm software developed by BrainLAB has received 510(k) clearance from the US FDA. The device uses the Monte Carlo method, a computational algorithm, to calculate doses of ionising radiation for use in radiosurgery. The software uses a 3D CT-scan of the patient's tissue to create an internal model of the patient and to calculate the dose distribution of the radiation emitted by a linear accelerator. The present implementation is designed to model photon radiation. Westchester, Illinois-based BrainLAB claims that the Monte Carlo algorithm is the "gold standard" for treatment planning accuracy, and contends that its software will help make high-precision treatment available in everyday clinical practice.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041672

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel